Literature DB >> 32676638

Variations in Health Care Utilization Patterns Among Inflammatory Bowel Disease Patients at Risk for High Medical Service Utilization Enrolled in High Deductible Health Plans.

Jeffrey A Berinstein1,2, Shirley A Cohen-Mekelburg1,2,3, Calen A Steiner1, Megan McLeod1, Mohamed Noureldin1,2, John I Allen1,2, Jeffrey T Kullgren2,3,4, Akbar K Waljee1,2,3, Peter D R Higgins1.   

Abstract

BACKGROUND: High-deductible health plans (HDHPs) are increasing in prevalence as a cost control device for slowing health care cost growth by reducing nonessential medical service utilization. High cost-sharing associated with HDHPs can lead to significant financial distress and worse disease outcomes. We hypothesize that chronic disease patients are delaying or foregoing necessary medical care due to health care costs.
METHODS: A retrospective cohort analysis of IBD patients at risk for high medical service utilization with continuous enrollment in either an HDHP or THP from 2009 to 2016 were identified using the MarketScan database. Health care costs were compared between insurance plan groups by Kruskal-Wallis test. Temporal trends in office visits, colonoscopies, emergency department (ED) visits, and hospitalizations were evaluated using additive decomposition time series analysis.
RESULTS: Of 605,862 patients with a diagnosis of IBD, we identified 13,052 eligible patients. Annual out-of-pocket costs were higher in the HDHP group (n = 524) than the THP group (n = 12,458) ($2870 vs $1,864; P < 0.001) without any difference in total health care expenses ($23,029 vs $23,794; P = 0.583). Enrollment in an HDHP influenced colonoscopy, ED visit, and hospitalization utilization timing. Colonoscopies peaked in the fourth quarter, ED visits peaked in the first quarter, and hospitalizations peaked in the third and fourth quarter.
CONCLUSIONS: High-deductible health plan enrollment does not change the cost of care; however, it shifts health care costs onto patients and changes the timing of the care they receive. High-deductible health plans are incentivizing delays in obtaining health care with a potential to cause worse disease outcomes and financial distress. Further evaluation is warranted.
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IBD; cost-sharing; health insurance; health plans; health services; high deductible; out-of-pocket costs; outcomes

Mesh:

Year:  2021        PMID: 32676638      PMCID: PMC9034205          DOI: 10.1093/ibd/izaa179

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   7.290


  30 in total

1.  Do consumer-directed health plans drive change in enrollees' health care behavior?

Authors:  Anna Dixon; Jessica Greene; Judith Hibbard
Journal:  Health Aff (Millwood)       Date:  2008 Jul-Aug       Impact factor: 6.301

2.  Impact of high-deductible health plans on health care utilization and costs.

Authors:  Teresa M Waters; Cyril F Chang; William T Cecil; Panagiotis Kasteridis; David Mirvis
Journal:  Health Serv Res       Date:  2010-10-28       Impact factor: 3.402

3.  Measuring the Burden of Health Care Costs on US Families: The Affordability Index.

Authors:  Ezekiel J Emanuel; Aaron Glickman; David Johnson
Journal:  JAMA       Date:  2017-11-21       Impact factor: 56.272

4.  Corrigendum to The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.

Authors:  K T Park; Orna G Ehrlich; John I Allen; Perry Meadows; Eva M Szigethy; Kim Henrichsen; Sandra C Kim; Rachel C Lawton; Sean M Murphy; Miguel Regueiro; David T Rubin; Nicole M Engel-Nitz; Caren A Heller
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

5.  The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study.

Authors:  Annelies Boonen; Pieter C Dagnelie; Anita Feleus; Martine A Hesselink; Jean W Muris; Reinhold W Stockbrügger; Maurice G Russel
Journal:  Inflamm Bowel Dis       Date:  2002-11       Impact factor: 5.325

6.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

7.  The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.

Authors:  Michael L Ganz; Rebecca Sugarman; Rosa Wang; Brian Bekker Hansen; Jonas Håkan-Bloch
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

8.  Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey.

Authors:  Teresa Longobardi; Philip Jacobs; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

9.  Increased risk for inflammatory bowel disease in congenital hypothyroidism supports the existence of a shared susceptibility factor.

Authors:  Helmut Grasberger; Mohamed Noureldin; Timothy D Kao; Jeremy Adler; Joyce M Lee; Shrinivas Bishu; Mohamad El-Zaatari; John Y Kao; Akbar K Waljee
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

10.  Global Internet Data on the Interest in Antibiotics and Probiotics Generated by Google Trends.

Authors:  Kamiński Mikołaj; Łoniewski Igor; Marlicz Wojciech
Journal:  Antibiotics (Basel)       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.